Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e403d809a4fd37c338115a0264067c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac7b9a9e4e7bd95a621a96ed88730b12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3df8c441feb97cc4caf75a68370e6686 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 |
filingDate |
2003-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5938c523bec44b67cdaefc5fe29c5a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049c14674747dc6679a490bb2b827c54 |
publicationDate |
2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03105058-A2 |
titleOfInvention |
Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom |
abstract |
The present invention relates to a method for structure-based prediction of properties of peptides and peptide analogs in complex with major histocompatibility (MHC) class I and class II molecules. The said properties mainly relate to the three-dimensional structure of an MHC/peptide complex and the binding affinity of a peptide for an MHC receptor. The invention further relates to a computer program and a device therefor. The invention further relates to data produced by a method of the invention. The invention further relates to peptides and peptide analogs predicted to bind to target-MHC molecules. The present invention thus relates to the field of immunology, with possible applications in manufacture of vaccinates, de-immunization of proteins, and manufacture of therapeutic agents, especially immunotherapeutic agents. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012072088-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013182661-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3338798-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008025015-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8538706-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023180346-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10501499-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008025015-A3 |
priorityDate |
2002-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |